发明授权
US07319100B2 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
有权
取代的吡嗪酮，吡啶和嘧啶作为促肾上腺皮质激素释放因子配体
- 专利标题： Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
- 专利标题（中）： 取代的吡嗪酮，吡啶和嘧啶作为促肾上腺皮质激素释放因子配体
-
申请号： US11675012申请日： 2007-02-14
-
公开(公告)号： US07319100B2公开(公告)日： 2008-01-15
- 发明人: Argyrios G. Arvanitis , Paul J. Gilligan , Richard A. Hartz
- 申请人： Argyrios G. Arvanitis , Paul J. Gilligan , Richard A. Hartz
- 申请人地址： US NJ Princeton
- 专利权人： Bristol-Myers Squibb Pharma Company
- 当前专利权人： Bristol-Myers Squibb Pharma Company
- 当前专利权人地址： US NJ Princeton
- 代理机构： Woodcock Washburn LLP
- 代理商 Shah R. Makujina
- 主分类号： C07D401/04
- IPC分类号： C07D401/04 ; C07D403/04 ; A61K31/4709 ; A61K31/497 ; A61P25/22 ; A61P25/24 ; C07D215/12 ; A61K31/506
摘要：
Compounds provided herein are novel substituted pyrazinones, pyridines and pyrimidines of Formula (I) and (II): Such compounds are particularly useful as CRF receptor ligands, and hence, in the treatment of various neurologically-related disorders such as affective disorder, anxiety and depression.